The overall objective of this research is to gain a better understanding of the structural requirements of dopamine agonist (DA) and antagonist activity. The study is centered about the use of a unique non-nitrogen-containing set of DA agonists. Although most investigators have envisioned an uncharged nitrogen as an essential portion of the molecular makeup of agonists and antagonists of DA receptors, we hypothesize that the major role of the nitrogen is to provide a cationic charge on the side chain of the DA molecule, which in turn can bind to an anionic site on the DA receptor. Our initial studies with sulfonium analogs of DA have shown them to possess significant dopamineric activity. In contrast, an uncharged sulfur analog was inactive as a DAergic agonist. We plan to continue these studies with DAergic agonists and to extend these studies to determine the molecular form of DAergic antagonist (charged or uncharged) responsible for antagonist activity. We plan to study the behavioral and biochemical effects of these compounds to determine how these compounds interact with various DA receptor systems (presynaptic, postsynaptic, D1 and D2).
The specific aim of these experiments is to synthesize and characterize several sulfur- and amine-containing agonists and antagonists and determine the molecular form required for agonist and antagonist activity. We will test the effectiveness of the various compounds on several model DAergic receptor systems. These will include 1) the K+ induced release of 3H-acetylcholine from straital slices; 2) circling behavior after the intrastriatal injection of drugs to rats - pretreated with 6-hydroxydopamine; 3) locomotor activity after injection of drugs into the nucleus accumbens of rats; 4) Prolactin release from anterior pituitary cells in culture; 5) inhibition of the binding of radioactive agonist and antagonist drugs. In addition, we will study the effects of the various drugs on the biochemistry of DAergic neurons and on noradrenergic receptor systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS017907-05
Application #
3397918
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1981-12-01
Project End
1987-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Pharmacy
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Farooqui, T; Brooks, K; Harrold, M W et al. (1994) Interaction of permanently charged metoclopramide analogs with D-2 dopamine receptors. Gen Pharmacol 25:1577-84
Farooqui, T; Markovich, K; Wallace, L et al. (1993) Interaction of AZA analogs of chlorpromazine with the dopamine D2 receptor. Gen Pharmacol 24:147-51
Harrold, M W; Sriburi, A; Matsumoto, K et al. (1993) The interaction of ammonium, sulfonium, and sulfide analogues of metoclopramide with the dopamine D2 receptor. J Med Chem 36:3166-70
Willins, D L; Wallace, L J; Miller, D D et al. (1992) alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs. J Pharmacol Exp Ther 260:1145-51
Harrold, M W; Wallace, R A; Farooqui, T et al. (1989) Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride. J Med Chem 32:874-80
Wallace, R A; Farooqui, T; Wallace, L et al. (1988) Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor. Biochem Pharmacol 37:2077-84
Ross, P C; Burkman, A M (1988) Inhibition of prolactin release from anterior pituitary lactotrophs in culture by sulfur-containing analogs of dopamine. Proc Soc Exp Biol Med 188:87-91
Chang, Y A; Ares, J; Anderson, K et al. (1987) Dopamine agonists: effects of charged and uncharged analogues of dopamine. J Med Chem 30:214-8
Harrold, M W; Chang, Y A; Wallace, R A et al. (1987) Charged analogues of chlorpromazine as dopamine antagonists. J Med Chem 30:1631-5
Sabol, B; Boldry, R; Farooqui, T et al. (1987) Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices. Biochem Pharmacol 36:1679-85

Showing the most recent 10 out of 12 publications